The effect of the supplemental intake of isoflavone and a zinc-containing mineral mixture on bone components in the femoral tissue of rats was investigated. Rats (5 weeks old) were orally administered either vehicle, isoflavone glycoside (5 mg/100 g body weight), aglycone isofavone (5 mg/100 g, including 3.772 mg daidzein, 0.395 mg genistein, and 0.833 mg glycitein), zinc-containing mineral mixture (0.833 mg zinc, 50 mg calcium, 25 mg magnesium, and 0.208 µg vitamin D 3 per 100 g body weight, respectively), or both aglycone isoflavone (5 mg/100 g) and zinc-containing mineral mixture for 7 d. Administrations resulted in a significant increase in femoral dry weight, calcium content, alkaline phosphatase activity, and DNA content in the femoral-diaphyseal and metaphyseal tissues. Femoral zinc content was significantly increased by the administration of zinc-containing mineral mixtures with or without aglycone isoflavone. The effect of aglycone isoflavone in elevating bone components was significantly enhanced in combination with the zinc-containing mineral mixture. Moreover, the oral administration of both aglycone isoflavones and zinc-containing mineral mixture to aged rats (50 weeks old) for 21 d resulted in a significant increase in femoral dry weight, zinc content, and bone components. This study demonstrates that supplemental intake of both aglycone isoflavone and a zinc-containing mineral mixture has an anabolic effect on bone components in aged rats, suggesting the role of nutrients in the prevention of osteoporosis with increasing age.
INTRODUCTION
Bone loss with increasing age induces osteoporosis. [1] [2] [3] This loss may be due to increased bone resorption and decreased bone formation. Osteoporosis with a decrease in bone mass is widely recognized as a major public health problem. 4) Pharmacological and nutritional factors may have the potential to prevent bone loss with increasing age. Nutritional factors may be especially important in the prevention of osteoporosis, although this is poorly understood.
Isoflavone glycoside (daidzin, genistin, and glycitin) and aglycone isoflavone (daidzein, genistein, and glycitein) are present in soybeans at comparatively high concentrations. Recently, it has been demonstrated that isoflavones have an anabolic effect on bone metabolism in rats, [5] [6] [7] [8] [9] suggesting a role in the prevention of osteoporosis. Daidzin, genistin, and glycitin are hydrolyzed to daidzein, genistein, and glycitein, respectively, by β-glucosidase in gastric juice. Daidzein and genistein have been shown to stimulate osteoblastic bone formation 10, 11) and to inhibit osteoclastic resorption, 12, 13) thereby increasing bone mass. Zinc, an essential trace element, has been demonstrated to have a potent stimulatory effect on bone formation 14, 15) and an inhibitory effect on bone resorption. 15) Zinc can stimulate protein synthesis in osteoblastic cells in vitro by activating aminoacyltRNA synthetase. 16, 17) The oral administration of a zinc compound can prevent bone loss in ovariectomized rats, 18) an animal model of osteoporosis. Whether the combination of nutritional factors reveals an additive or synergistic effect on bone com- 363-369 (2000) ponents has not been fully determined. This knowledge may be important in the prevention of bone loss with increasing age. Recently, it has been shown that the combination of genistein and zinc can have a synergistic effect on bone components in femoral tissue from elderly female rats. 19 ) Furthermore, we found that the supplemental intake of an aglycone isoflavone-containing zinc and mineral mixture can increase bone components in the femoral tissue of both young and aged rats.
MATERIALS AND METHODS
Animals ---Female Wistar rats (conventional) weighing 100-110 g (5 weeks old) or 210-240 g (50 weeks old) were obtained from Japan SLC (Hamamatsu, Japan). The animals were fed commercial laboratory chow (solid) containing 1.1% calcium and phosphorus at a room temperature of 25°C, with free access to distilled water. Administration Procedures ---For group 1, a powder of isoflavone glycoside containing daidzin (3.772 mg), genistin (0.395 mg) and glycitin (0.833 mg) was suspended in distilled water (1 ml). For group 2, aglycone isoflavones including daidzein (3.772 mg), genistein (0.395 mg), and glycitein (0.833 mg) were also suspended in distilled water (1 ml). For group 3, a zinc-containing mineral mixture consisting of zinc yeast (0.833 mg Zn), coralderived calcium (50 mg), magnesium (25 mg), and vitamin D 3 (0.208 µg) was mixed and suspended in distilled water (1 ml). For group 4, the aglycone isoflavones of group 2 and the zinc-containing mineral mixture of group 3 were suspended in distilled water (1 ml). These suspensions (1 ml/100 g body weight) were orally administered to young rats (5 weeks old) through a stomach tube once a day for 7 d, and 24 h after the last administration the animals were killed by cardiac puncture under light ether anesthesia, and the blood and femur were removed immediately.
In another experiment, aged rats (50 weeks old) were orally administered the suspension (1 ml/100 g body weight) of aglycone isoflavones and zinc-containing mineral mixture through a stomach tube once a day for 7 or 21 d, and 24 h after the last administration the animals were killed by desanguination. This supplement contained aglycone isoflavones (including 3.772 mg daidzein, 0.395 mg genistein, and 0.833 mg glycitein), zinc yeast (0.833 mg Zn), coralderived calcium (50 mg) and magnesium (25 mg), vitamin D 3 (0.208 µg), and sugar ester (16.6 mg) per tablet. This tablet was powdered and suspended in distilled water (one tablet/ml). Analytical Procedures ---Blood samples were centrifuged for 30 min after collection, and the serum was separated and analyzed immediately. Serum calcium and zinc were determined by atomic absorption spectrophotometry. 14, 20) Serum inorganic phosphorus was measured by the method of Tausky and Shon. 21) Serum albumin, nitrogen urea, triglyceride, free cholesterol and HDL chlestrol were measured using KIT (Wako Pure Chemical Industries, Ltd., Osaka, Japan). Serum estradiol was assayed using a double-antibody radioimmunoassay method using the RI KIT.
The diaphyseal and metaphyseal tissues were dried for 16 h at 110°C and weighed. Bone tissues were digested for 24 h at 110°C. Calcium was determined by atomic absorption spectrophotometry. 22) The calcium content in bone tissues was expressed as milligram per gram of dry bone.
To assay alkaline phosphatase activity, the diaphyseal and metaphyseal tissues were immersed in 3.0 ml of ice-cold 6.5 mM barbital buffer (pH 7.4), cut into small pieces, homogenized with a Physcotron homogenizer, and disrupted for 60 s with an ultrasonic device. The supernatant centrifuged at 600 × g for 5 min was used to measure enzyme activity. Enzyme assay was carried out under optimal conditions. Alkaline phosphatase activity was determined by the method of Walter and Schutt. 23) Enzyme activity was expressed as µmol of pnitrophenol liberated per minute per milligram of protein. The protein concentration was determined by the method of Lowry et al. 24) To measure bone DNA content, the diaphyseal and metaphyseal tissues were shaken with 4.0 ml of ice-cold 0.1 N NaOH solution for 24 h after homogenization of the bone tissues. 25) After alkali extraction, the samples were centrifuged at 1000 × g for 5 min, and the supernatant was collected. DNA content in the supernatant was determined by the method of Ceriotti 26) and expressed as the amount of DNA (milligrams)/gram weight of bone tissue. Statistical Analysis ---The significance of the difference between values was estimated by Student's t-test. p-Values of less than 0.05 were considered to indicate statistically significant differences. We also used a multiway analysis of variance (ANOVA) and Turky-Kramer multiple comparison test to compare the treatment groups. Rats (5 weeks old) were orally administered either vehicle, isoflavone glycoside (5 mg/100 g body weight), aglycone isoflavone (5 mg/100 g), zinc-containing mineral mixture (833 µg zinc, 50 mg calcium, 25 mg magnesium and 0.208 µg vitamin D 3 per 100 g body weight, respectively), or aglycon isoflavone (5 mg/100 g) and zinccontaining mineral mixture for 7 d, and 24 h after the last administration the animals were killed by exsanguination. Each value is the mean ± S.E.M. of six rats. * p < 0.01, compared with the control value. # p < 0.01, compared with the value for isoflavone glycoside or aglycone isoflavone administration. , Control; , isoflavone glycoside;
, aglycone isoflavone; , zinc-containing mineral mixture; , aglycone isoflavone and zinc-containing mineral mixture. Rats were administered isoflavones as described in the legend to Fig. 1 . Each value is the mean ± S.E.M. of six animals. * p < 0.01, compared with the control value. # p < 0.05, compared with the control value. , Control; , isoflavone glycoside;
, aglycone isoflavone; , zinc-containing mineral mixture; , aglycone isoflavone and zinccontaining mineral mixture.
RESULTS

Effect of Isoflavones and Zinc-Containing Mineral Mixture on Bone Components in Young Rats
Rats (5 weeks old) were orally administered either isoflavone glycoside (5 mg/100 g body weight), aglycone isoflavone (5 mg/100 g, including 3.772 mg daidzein, 0.395 mg genistein, and 0.873 mg glycitein), the zinc (833 µg/100 g)-containing mineral (50 mg calcium/100 g, 25 mg magnesium/100 g, and 0.208 µg vitamin D 3 /100 g) mixture, or both aglycone isoflavone and the zinc-containing mineral mixture for 7 d. Body weight of animals was not significantly altered by the administration of isoflavones, the zinc-containing mineral mixture, or their combination as compared with that of control rats (data not shown). The serum calcium, inorganic phosphorus, and zinc concentration was not significantly changed by administration (data not shown).
Femoral dry weight was significantly increased by the administration of isoflavone glycoside, aglycone isoflavone, or zinc-containing mineral mixture (Fig. 1) . The effect of isoflavones in increasing femoral dry weight was significantly enhanced by the combination of aglycone isoflavone and zinc-containing mineral mixture.
Zinc content in the femoral-diaphyseal and metaphyseal tissues was significantly increased by the administration of the zinc-containing mineral mixture with or without aglycone isoflavone as compared with that of control rats (Fig. 2) . This increase was not seen with the administration of isoflavone glycoside or aglycone isoflavone.
Calcium content, alkaline phosphatase activity, and DNA content in the femoral-diaphyseal and metaphyseal tissues were significantly elevated by the administration of isoflavone glycoside or aglycone isoflavone, zinc-containing mineral mixture, or both aglycone isoflavone and zinc-containing mineral mixture (Figs. 3, 4 , and 5). These increases in the femoral-metaphyseal tissues were significantly enhanced by the combination of both aglycone isoflavone and zinc-containing mineral mixture compared with that of isoflavone glycoside, aglycone isoflavone or zinc-containing mineral mixture alone (Figs. 3, 4 , and 5).
Effect of Supplemental Intake of Aglycone Isoflavone and Zinc-Containing Mineral Mixture on Bone Components in Aged Rats
Rats (50 weeks old) were orally administered the suspension (1 ml/100 g body weight) of supplemental tablets containing aglycone isoflavone (5 mg/ml, Rats were administered isoflavones as described in the legend to Fig. 1 . Each value is the mean ± S.E.M. of six animals. * p < 0.05 and ** p < 0.01, compared with the control value. # p < 0.01, compared with the value for isoflavone glycoside or aglycone isoflavone administration. , Control; , isoflavone glycoside;
, aglycone isoflavone; , zinccontaining mineral mixture; , aglycone and zinc-containing mineral mixture. Rats were administered isoflavones as described in the legend to Fig. 1 . Each value is the mean ± S.E.M. of six animals. * p < 0.01, compared with the control value. # p < 0.01, compared with the value from isoflavone glycoside or aglycone isoflavone administration.
Fig. 3. Changes in Calcium Content in the Femoral-Diaphyseal and Metaphyseal Tissues of Young Rats Orally Administered Isoflavones and Zinc-Containing Mineral Mixture
Rats were administered isoflavones as described in the legend to Fig. 1 . Each value is the mean ± S.E.M. of six animals. * p < 0.01, compared with the control value. # p < 0.01, compared with the value for isoflavone glycoside or aglycone isoflavone administration. , Control; , isoflavone glycoside;
, aglycone isoflavone; , zinccontaining mineral mixture; , aglycone isoflavone and zinc-containing mineral mixture. including 3.772 mg daidzein, 0.395 mg genistein, and 0.833 mg glycitein), zinc (833 µg/ml), calcium (50 mg/ml), magnesium (25 mg/ml), and vitamin D 3 (0.208 µg/ml) for 7 or 21 d. Serum calcium and inorganic phosphorus concentrations in aged rats were significantly reduced as compared with those in young rats (5 weeks old) ( Table 1) . They were not significantly altered by the administration of aglycone isoflavone and zinc-containing mineral mixture. The serum zinc concentration decreased slightly with increasing age. This level was significantly elevated with the administration of aglycone isoflavone and zinc-containing mineral mixture ( Table 1 ). The serum concentration of albumin, nitrogen urea, triglyceride, free cholesterol, HDL chlesterol, and 17 β-estradiol in aged rats was not significantly altered by the administration of agly- Rats (50 weeks old) were orally administered the suspension (1 ml/100 g body weight) of supplement containing aglycone isoflavone (5 mg/ml), zinc (833 µg/ml), calcium (50 mg/ml), magnesium (25 mg/ml), and vitamin D 3 (0.208 µg/ml) for 7 or 21 d. Each value is the mean ± S.E.M. of six animals. # p < 0.01, compared with the control value obtained from 5-week-old rats. * p < 0.025 and * * p < 0.01, compared with the control value of aged rats.
cone isoflavone and zinc-containing mineral mixture for 7 or 21 d (data not shown). Body weight did not change in rats administered the supplements (data not shown). These results indicate that the supplemental intake had no toxic effect.
The femoral dry weight of aged rats was significantly increased with the administration of aglycone isoflavone and zinc-containing mineral mixture for 21 d (Fig. 6) .
The zinc content in the femoral-diaphyseal and metaphyseal tissues of aged rats was significantly increased with the administration of aglycone isoflavone and zinc-containing mineral mixture for 7 or 21 d (Fig. 7) . Calcium content, alkaline phosphatase activity, and DNA content in the femoraldiaphyseal and metaphyseal tissues of aged rats were significantly elevated with the administration of aglycone isoflavone and zinc-containing mineral mixture (Figs. 8, 9 , and 10).
DISCUSSION
Osteoporosis is widely recognized as a major public health problem. Nutritional factors may be Rats (50 weeks old) were orally administered the suspension (1 ml/ 100 g body weight) of supplement containing aglycone isoflavone (5 mg/ ml), zinc (833 µg/ml), calcium (50 mg/ml), magnesium (25 mg/ml), and vitamin D 3 (0.208 µg/ml) for 7 or 21 d, and 24 h after the last administration the animals were killed by exsanguination. Each value is the mean ± S.E.M. of six rats. * p < 0.01, compared with the control value. Rats were administered the supplement as described in the legend to Fig. 6 . Each value is the mean ± S.E.M. of six rats. *p < 0.05 and **p < 0.01, compared with the control value.
important in preventing bone loss with increasing age. Recently, it has been demonstrated that aglycon isoflavone (daidzein and ginistein), which is present in soybeans, has an anabolic effect on bone metabolism. [5] [6] [7] [8] [9] Zinc, an essential trace element, has been shown to have a potent stimulatory effect on bone formation and an inhibitory effect on bone resorption, [14] [15] [16] [17] [18] increasing bone mass. Dietary supplementation with a combination of isoflavone and zinc may be important in the prevention of bone loss with increasing age. The present study demonstrates that the supplemental intake of isoflavone and a zinccontaining mineral mixture has a stimulatory effect on bone components in the femoral tissues of young and aged rats.
We administered isoflavone glycoside (including daidzin, genistin, and glycitin) and aglycone isoflavone (including daidzein, genistein, and glycitein) to rats. Isoflavone glycoside is hydrolyzed to aglycone isoflavone by β-glucosidase in gastric juice. The oral administration of isoflavone glycoside or aglycone isoflavone to young rats for 7 d caused a significant increase in femoral dry weight, calcium content, alkaline phosphatase activity and DNA content in the femoral-diaphyseal and metaphyseal tissues of young rats. The effect of isoflavone glycoside or aglycone isoflavone in elevating bone components was equivalent, suggesting that isoflavone glycoside is partly converted to aglycone isoflavone. Alkaline phosphatase is a marker enzyme of osteoblasts, and the enzyme participates in bone mineralization. 27) DNA content is an index of bone growth and of a number of bone cells including osteocytes, osteoblasts, and osteoclasts in bone tissues. 28) Presumably, aglycone isoflavone has a stimulatory effect on osteoblastic bone formation and mineralization in rats.
Zinc has been demonstrated to have a potent stimulatory effect on bone formation. 15) Our zinccontaining mineral mixture was composed of zinc yeast, coral-derived calcium and magnesium, and Rats were administered supplement as described in the legend to Fig. 6 . Each value is the mean ± S.E.M. of six animals. * p < 0.05 and ** p < 0.01, compared with the control value.
vitamin D 3 whic has been reported to have a stimulatory effect on intestinal calcium absorption.
29) The administration of the zinc-containing mineral mixture had an anabolic effect on bone components in young rats, confirming its stimulatory effect on bone formation and mineralization.
The combination of aglycone isoflavone and zinc-containing mineral mixture had an additive enhancing effect on bone components in young rats. This enhanced effect may have resulted from the action of daidzein, genistein, and zinc on osteoblastic cells in the femoral tissues, since these factors are known to stimulate osteoblastic cell function. 10, 11, 15, 16) Moreover, the supplemental tablets, including aglycone isoflavone and zinc-containing mineral mixture, for 21 d caused a significant elevation of femoral dry weight, zinc content, calcium content, alkaline phosphatase activity, and DNA content in the femoral-diaphyseal and metaphyseal tissues of aged rats. Bone metabolism deteriorates with increasing age. This finding suggests that the supplemental intake of aglycone isoflavone and zinccontaining mineral mixture can prevent bone loss with increasing age. The combination of nutritional factors presumably plays a benefical role in the prevention of osteoporosis.
In conclusion, it has been shown that the supplemental intake of isoflavone and zinc-containing mineral mixture has an anabolic effect on bone components in the femoral tissues of young and aged rats. Rats were administered supplement as described in the legend to Fig. 6 . Each value is the mean ± S.E.M. of six rats. * p < 0.05 and ** p < 0.025, compared with the control value.
